Biotech · Private company
MultiVir, Inc.
Track this companyFree. Adds MultiVir, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- Ad-p53Phase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- Ad-P53Phase 2 · Metastatic Solid Tumor CancerClinicalTrials.gov · fetched Nov 12, 2026
- KeytrudaPhase 2 · Metastatic Solid Tumor CancerClinicalTrials.gov · fetched Nov 12, 2026
- OpdivoPhase 2 · Metastatic Solid Tumor CancerClinicalTrials.gov · fetched Nov 12, 2026
- XelodaPhase 2 · Metastatic Solid Tumor CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Safety and Efficacy of Intra-Arterial and Intra-Tumoral Ad-p53 With Capecitabine (Xeloda) or Anti-PD-1 in Liver Metastases of Solid Tumors and Recurrent Head and Neck Squamous Cell CancerPHASE1_PHASE2 · TERMINATED · started Nov 20, 2018ClinicalTrials.gov NCT02842125 · fetched Nov 12, 2026
- Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.PHASE2 · UNKNOWN · started Oct 1, 2018ClinicalTrials.gov NCT03544723 · fetched Nov 12, 2026
- Combination Immunotherapy-Ipilimumab-Nivolumab-Dendritic Cell p53 Vac - Patients With Small Cell Lung Cancer (SCLC)PHASE2 · TERMINATED · started Mar 15, 2018ClinicalTrials.gov NCT03406715 · fetched Nov 12, 2026